Margenza

pay deal hand over cash licensing transaction money

Pharma

TerSera picks up MacroGenics' Margenza for $40M plus milestones

The 2020-approved breast cancer med booked $17.9 million in 2023 sales as it struggled to make a mark in the crowded market.

Zoey Becker Oct 22, 2024 11:33am

National Breast Cancer Awareness Month pink ribbon

MacroGenics' Margenza fails to extend life over Herceptin

Sep 8, 2021 10:10am

Stamp with blue ink that says FDA Approved

MacroGenics wins breast cancer nod with Herceptin-topping data

Dec 17, 2020 11:53am